Freedom Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-918
Closed -$210K 806
2024
Q4
$210K Buy
+918
New +$221K 0.02% 705
2021
Q1
Sell
-1,828
Closed -$389K 894
2020
Q4
$389K Sell
1,828
-1,538
-46% -$307K 0.04% 405
2020
Q3
$577K Buy
3,366
+586
+21% +$108K 0.06% 257
2020
Q2
$534K Sell
2,780
-1,576
-36% -$258K 0.06% 257
2020
Q1
$747K Buy
4,356
+102
+2% +$16.2K 0.07% 245
2019
Q4
$659K Sell
4,254
-773
-15% -$111K 0.06% 277
2019
Q3
$679K Sell
5,027
-1,111
-18% -$146K 0.06% 287
2019
Q2
$749K Sell
6,138
-997
-14% -$110K 0.06% 271
2019
Q1
$742K Buy
7,135
+3,579
+101% +$369K 0.06% 296
2018
Q4
$405K Sell
3,556
-258
-7% -$27.6K 0.03% 481
2018
Q3
$427K Buy
3,814
+105
+3% +$11.5K 0.03% 593
2018
Q2
$384K Sell
3,709
-137
-4% -$13.9K 0.02% 670
2018
Q1
$379K Sell
3,846
-229
-6% -$21.6K 0.02% 787
2017
Q4
$345K Sell
4,075
-208
-5% -$17.2K 0.02% 825
2017
Q3
$330K Sell
4,283
-747
-15% -$57.1K 0.02% 798
2017
Q2
$392K Sell
5,030
-13
-0.3% -$930 0.02% 671
2017
Q1
$363K Sell
5,043
-5,453
-52% -$377K 0.02% 667
2016
Q4
$651K Buy
10,496
+2,601
+33% +$159K 0.04% 396
2016
Q3
$512K Sell
7,895
-4,935
-38% -$328K 0.03% 442
2016
Q2
$811K Buy
12,830
+4,943
+63% +$291K 0.06% 273
2016
Q1
$456K Sell
7,887
-3,683
-32% -$208K 0.03% 431
2015
Q4
$621K Sell
11,570
-5,846
-34% -$330K 0.05% 329
2015
Q3
$844K Buy
17,416
+9,879
+131% +$532K 0.09% 195
2015
Q2
$425K Buy
7,537
+2,753
+58% +$174K 0.04% 392
2015
Q1
$343K Buy
+4,784
New +$311K 0.04% 435

Other funds holding RMD

Freedom Investment Management's RMD Position: Q1 2025 in Review

Freedom Investment Management sold out of ResMed (RMD) in Q1 2025, closing a stake of 918 shares — an estimated $210K sold.

Freedom Investment Management first reported a position in RMD in Q1 2015 and held it in 25 quarters. The position peaked at $844K in Q3 2015. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Freedom Investment Management reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Freedom Investment Management sold 918 ResMed shares in Q1 2025, an estimated $210K.
  • Freedom Investment Management first reported a position in ResMed in Q1 2015 and held it in 25 quarters.
  • Freedom Investment Management's ResMed position peaked at $844K in Q3 2015.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Freedom Investment Management's 13F filing for Q1 2025, filed 14 May 2025.